Interleukin 6 expression in coronary circulation after coronary angioplasty as a risk factor for restenosis

Heart

Volumn 84, Issue 1, 2000, Pages 83-87

  Hojo, Y ^a   Ikeda, U ^a   Katsuki, T ^a   Mizuno, O ^a   Fukazawa, H ^a   Kurosaki, K ^a   Fujikawa, H ^a   Shimada, K ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Cytokine; Inflammation; Restenosis

Indexed keywords

INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0033933413     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.84.1.83     Document Type: Article

References (26)

1. Kranzhöfer R, Clinton SK, Ishii K, et al. Thrombin potentially stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes. Circ Res 1996;79:286-94.
2. Jordan NJ, Watson ML, Williams RJ, et al. Chemokine production by human vascular smooth muscle cells; modulation by IL-13. Br J Pharmacol 1997;122:749-57.
3. Mitsumata M, Fishel RS, Nerem RM, et al. Fluid shear stress stimulates platelet-derived growth factor expression in endothelial cells. Am J Physiol 1993;265:H3-8.
4. Ikeda U, Ohkawa F, Seino Y, et al. Serum interleukin 6 levels become elevated in acute myocardial infarction. J Mol Cell Cardiol 1992;24:579-84.
5. Kukielka GL, Smith W, LaRosa GJ, et al. Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. J Clin Invest 1995;95:89-103.
6. Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995;92:748-55.
7. Biasucci LM, Vitelli AA, Liuzzo G, et al. Elevated levels of interleukin-6 in unstable angina. Circulation 1996;94:874-7.
8. Marx N, Neuman FJ, Ott I, et al. Induction of cytokine expression in leukocytes in acute myocardial infarction. J Am Coll Cardiol 1997;30:165-70.
9. Libby P, Schwartz D, Brogi E, et al. A cascade model for restenosis. a special case of atherosclerosis progression. Circulation 1992;86(suppl III):III-47-52.
10. Inoue T, Sakai Y, Hoshi K, et al. Lower expression of neutrophil adhesion molecule indicates less vessel wall injury and might explain lower restenosis rate after cutting balloon angioplasty. Circulation 1998;97:2511-18.
11. Kowalski J, Kosmider M, Pawlicki L, et al. Complement activates neutrophils during PTCA procedure in patients with unstable angina pectoris. Int J Cardiol 1996;58:229-40.
12. Serrano CV, Ramires JAF, Venturinelli M, et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. J Am Coll Cardiol 1997;29: 1276-83.
13. Blum A, Sclarovsky S, Shohat B. T lymphocyte activation in stable angina pectoris and after percutaneous transluminal coronary angioplasty. Circulation 1995;91:20-2.
14. Liuzzo G, Buffon A, Biasucci LM, et al. Enhanced inflammatory response to coronary angioplasty in patients with severe unstable angina. Circulation 1998;98:2370-6.
15. Gimple LW, Herrmann HC, Winnford M, et al, for the Ardeparin and Restenosis Study Group. Usefulness of subcutaneous low molecular weight heaprin (Ardeparin) for reduction of restenosis after percutaneous transluminal coronary angioplasty. Am J Cardiol 1999; 83:1524-9.
16. Rue HG, Vlaicu R, Niculescu F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996;127:263-71.
17. Seino Y, Ikeda U, Ikeda M, et al. Interleukin 6 gene transcripts are expressed in human atherosclerotic lesions. Cytokine 1994;6:87-91.
18. Pietersma A, Kofflard M, de Wit EA, a al. Late lumen loss after coronary angioplasty is associated with the activation status of circulating phagocytes before treatment. Circulation 1995;91:1320-5.
19. Montalescot G, Ankri A, Vicaut E, et al. Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation 1995;92:31-8.
20. Ganter U, Arcone R, Toniatti C, et al. Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6. EMBOJ 1989;8:3773-9.
21. Mestries JC, Kruithof EKO, Gascon MP, et al. In vivo modulation of coagulation and fibrinolysis by recombinant glycosilated human interleukin-6 in baboons. Eur Cytokine Netw 1994;5:275-81.
22. van der Poll T, Levi M, Hack CE, et al. Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994;179:1253-9.
23. Stouthard JML, Levi M, Hack CE, et al. Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 1996;94:874-7.
24. Ikeda U, Ikeda M, Oohara T, et al. Interleukin-6 stimulates the growth of vascular cells in a PDGF dependent manner. Am J Physiol 1991;260:H1713-17.
25. Filonzi EL, Zoellner H, Stanton H, et al. Cytokine regulation of granulocyte-macrophage colony stimulating factor and macrophage colony stimulating factor production in human arterial smooth muscle cells. Atherosclerosis 1993;99:241-52.
26. Caplice NM, Aroney CN, Bett JHN, et al. Growth factors released into the coronary circulation after vascular injury promote proliferation of human vascular smooth muscle cells in culture. J Am Coll Cardiol 1997;29:1536-41.